Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for medical industry professionals · Sunday, May 27, 2018 · 448,911,592 Articles · 3+ Million Readers

Global Active Pharmaceutical Ingredient 2017 Industry Trends, Sales, Supply, Demand, Analysis & Forecast to 2025

WiseGuyReports.com adds “Active Pharmaceutical Ingredient Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025”

PUNE, INDIA, November 20, 2017 /EINPresswire.com/ -- Summary

WiseGuyReports.com adds “Active Pharmaceutical Ingredient Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025” reports to its database.

This report provides in depth study of “Active Pharmaceutical Ingredient market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Active Pharmaceutical Ingredient Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug. 

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.: 
Teva 
Novartis 
Pfizer 
Johnson & Johnson 
Mylan 
North China Pharmaceutical Group 
Dr. Reddy’s Laboratories 
Roche 
Aurobindo pharma 
Sun Pharmaceutical Industries 
Boehringer Ingelheim GmbH 
Bayer 
BASF 
DSM 
Zhejiang Medicine 
Biocon 
Johnson Matthey 
Hisun Pharmacy 
Cambrex 
Shandong Xinhua Pharmaceutical 
Lonza group 
Huahai Pharmaceutical 
Haerbin Pharmaceutical Group 
Cipla 
Tian Yao 
Lupin 
North East Pharmaceutical 
Albemarle 
Shandong Lukang Pharmaceutical 
Jiangsu Hengrui Medicine 
Bachem 

Request a Sample Report @   https://www.wiseguyreports.com/sample-request/1837143-global-active-pharmaceutical-ingredient-market-data-survey-report-2025

The global Active Pharmaceutical Ingredient market will reach xxx Million USD in 2017 with CAGR xx% from 2018-2025. The main contents of the report including: 
Global market size and forecast 
Regional market size, production data and export & import 
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) 
Average market price by SUK 
Major applications 

Major applications as follows: 
Non-steroidal Anti-inflammatory Drugs (NSAIDs) 
Oncology Drugs 
Anti-diabetic Drugs 
Cardiovascular Drugs 
Central Nervous System Drugs (CNS Drugs) 
Musculoskeletal Drugs 
Other Drugs 

Regional market size, production data and export & import: 
Asia-Pacific 
North America 
Europe 
South America 
Middle East & Africa

At Any Query @ https://www.wiseguyreports.com/enquiry/1837143-global-active-pharmaceutical-ingredient-market-data-survey-report-2025

Table of Contents 

1 Global Market Overview 
1.1 Scope of Statistics 
1.1.1 Scope of Products 
1.1.2 Scope of Manufacturers 
1.1.3 Scope of Application 
1.1.4 Scope of Regions/Countries 
1.2 Global Market Size 

2 Regional Market 
2.1 Regional Production 
2.2 Regional Demand 
2.3 Regional Trade 

3 Key Manufacturers 
3.1 Teva 
3.1.2 Company Information 
3.1.2 Product Specifications 
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
3.2 Novartis 
3.2.1 Company Information 
3.2.2 Product Specifications 
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
3.3 Pfizer 
3.3.1 Company Information 
3.3.2 Product Specifications 
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
3.4 Johnson & Johnson 
3.4.1 Company Information 
3.4.2 Product Specifications 
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
3.5 Mylan 
3.5.1 Company Information 
3.5.2 Product Specifications 
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
3.6 North China Pharmaceutical Group 
3.6.1 Company Information 
3.6.2 Product Specifications 
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
3.7 Dr. Reddy’s Laboratories 
3.7.1 Company Information 
3.7.2 Product Specifications 
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
3.8 Roche 
3.8.1 Company Information 
3.8.2 Product Specifications 
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
3.9 Aurobindo pharma 
3.9.1 Company Information 
3.9.2 Product Specifications 
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
3.10 Sun Pharmaceutical Industries 
3.10.1 Company Information 
3.10.2 Product Specifications 
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
3.11 Boehringer Ingelheim GmbH 
3.12 Bayer 
3.13 BASF 
3.14 DSM 
3.15 Zhejiang Medicine 
3.16 Biocon 
3.17 Johnson Matthey 
3.18 Hisun Pharmacy 
3.19 Cambrex 
3.20 Shandong Xinhua Pharmaceutical 
3.21 Lonza group 
3.22 Huahai Pharmaceutical 
3.23 Haerbin Pharmaceutical Group 
3.24 Cipla 
3.25 Tian Yao 
3.26 Lupin 
3.27 North East Pharmaceutical 
3.28 Albemarle 
3.29 Shandong Lukang Pharmaceutical 
3.30 Jiangsu Hengrui Medicine 
3.31 Bachem 

4 Major Application 
4.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs) 
4.1.1 Overview 
4.1.2 Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Size and Forecast 
4.2 Oncology Drugs 
4.2.1 Overview 
4.2.2 Oncology Drugs Market Size and Forecast 
4.3 Anti-diabetic Drugs 
4.3.1 Overview 
4.3.2 Anti-diabetic Drugs Market Size and Forecast 
4.4 Cardiovascular Drugs 
4.4.1 Overview 
4.4.2 Cardiovascular Drugs Market Size and Forecast 
4.5 Central Nervous System Drugs (CNS Drugs) 
4.5.1 Overview 
4.5.2 Central Nervous System Drugs (CNS Drugs) Market Size and Forecast 
4.6 Musculoskeletal Drugs 
4.6.1 Overview 
4.6.2 Musculoskeletal Drugs Market Size and Forecast 
4.7 Other Drugs 
4.7.1 Overview 
4.7.2 Other Drugs Market Size and Forecast 

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1837143

Continued....

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire